Blog

In the rapidly evolving field of oncology, matching patients to the right clinical trials can be the key to unlocking new treatments and improving outcomes. Dr. Meera Ragavan, our subject matter expert in lung cancer, plays a critical role in ...

Dr. Charles Ryan, a medical oncologist with over 25 years of experience, has devoted much of his career to clinical research in prostate cancer, playing a crucial role in designing and conducting studies ranging from early-phase trials to ...

In this informative conversation, Dr. Hala Borno, CEO and Founder of Trial Library, sits down with Dr. Douglas Flora, Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, to discuss the vital role of clinical trials in ...

Healthcare Providers are the gatekeepers to patient access for cancer trials. Eight of ten patients who enroll in a cancer trial, do so because of a Healthcare Provider recommendation. However, as a healthcare provider, my experience today ...

Amanda is a dedicated Ally Navigator at Trial Library. She joined Trial Library with extensive patient care experience as a Registered Nurse. Amanda has dedicated her career to serving vulnerable populations through community organizing and ...

As a health technology company, Trial Library has prioritized the security of our platform and data from the very beginning. We are thrilled to announce that Trial Library has officially achieved SOC 2 Type 2 and HIPAA compliance certifications!

We are privileged to include Dr. Kashyap Patel as a Clinical and Scientific Advisor to Trial Library. Dr. Patel is a key opinion leader with extensive leadership experience in oncology. He is the current Chief Executive Officer of Carolina Blood ...

Dr. Josephson is a practicing Urologic Oncologist and partner at Tower Urology, a Los Angeles-based private practice of 10 physicians treating patients across Southern California. Dr. Josephson is one of the leading experts in robotic surgery, ...

Trial Library partners with oncologists in community oncology settings to engage in the clinical trial process, expanding patient access to cutting edge therapies and unlocking a new pool of research-engaged providers.

The estimated rates of cancer clinical trial participation among eligible patients remain between 5-7% with limited progress over the past two decades (source). Only 1 in 10 Americans reported ever being invited to participate in a clinical trial ...

Juli (pronounced “Hu-lee”) is one of our Ally Navigators at Trial Library. She was born in Medellín, Colombia, and has lived in New York, New Hampshire, California, and now Nevada! Throughout her travels, she is accompanied by her three-year-old ...

There are numerous examples of the harsh consequences of inadequate representation in clinical research such as the disregard for biological differences between male and female bodies. Researchers analyzed data from 5000 articles and observed a ...

I see offering clinical trials as an integral part of the delivery of cancer care. For my patients, clinical trials are an opportunity to access therapies and diagnostics that may improve quality and potentially duration of life. Clinical trials ...